London-based Punto Health, a HealthTech startup innovating dementia care, has received €100k plus a year-long mentorship program from NN Group and Rubio Impact Ventures.
The grant and mentorship programme were a result of winning the second edition of the NN Social Innovation Startup Award at The Next Web Conference.
“One in two people will be affected by dementia during their lifetime, and women are disproportionately impacted, both as patients and as carers,” says Anna Muñoz Farré, Co-founder and CEO of Punto Health. “This €100k grant from NN Group, combined with Rubio’s network and expertise in scaling impact startups, gives us everything we need to transform dementia care and help families better manage the rising burden globally.”
Founded in 2023 by Anna Muñoz Farré and Jack Eckersley, Punto Health aims to demonstrate how AI can transform crisis management into proactive family support, especially in the shadow of fragmented dementia care.
Their mission is to become the trusted companion empowering personalised care for those impacted by cognitive disease.
With years of accumulated expertise across the healthcare spectrum and innovative technologies, they design, validate and test their products involving patients, carers and clinicians at each step.
“We designed this award to champion early-stage social enterprises that provide innovative solutions for improving financial, physical and mental well-being. Developing products and services that create solutions for people at scale, is still a challenge for many social entrepreneurs to make the impact that they envision. The diversity of solutions this year shows that technology can truly be a force for good,” says Lonneke Roza, Head of Community Investment at NN Group. “From AI transforming dementia care to platforms redirecting digital talent toward cybersecurity – these are the innovations that make a difference for people who need it most.”
Farré was moved to create Punto Health after her grandfather was diagnosed with dementia, witnessing the gaps in the healthcare system. According to Punto, 78 million people will face dementia diagnosis by 2030.
As a result, Farré and Eckersley look to transform dementia care by empowering patients, families and healthcare providers with AI-driven personalised support.
Ilonka Jankovich, Venture Partner at Rubio Impact Ventures, adds: “Some of the most impactful startups are built by people with deep personal insight into the problems they’re solving. But turning that into a scalable business – especially in sectors like mental health, healthcare access, or financial resilience – is incredibly hard without the right kind of support. This award was created to fill that gap. Not just with funding, but with the guidance from NN Group and Rubio and the support of the community of innovators we’ve created with this competition. Each and every one is committed to changing the system, so that tech-driven solutions for well-being become the norm, not the exception.”
Punto Health currently offers two products:
PuntoCare: A smartphone/tablet app that offers daily support to people with cognitive impairment and their families. This includes personalised daily care plans, cognitive stimulation exercises, physical activity, healthy habits, relaxation, etc.; and articles providing clinically validated information curated by experts. The app features anAI assistant that interacts with content and provides answers, tips and strategies, along with a symptom diary that facilitates monitoring and management.
PuntoClinic: A speech-based digital biomarker for cognitive assessment to facilitate and improve remote monitoring of disease progression and early detection.
